There was a significant difference in the HIF-1α mRNA transcript levels between the 5 μmol/L ATRA group and the 10 μmol/L ATRA group in SHG44 glioma cells (P < 0.05). The gene discussed is HIF1A; the disease is central nervous system cancer.